BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
ZBAO
Zhibao Technology Inc. Class A Ordinary Shares
There isn't enough reported data to score ZBAO yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ZBAO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
ZBAO's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like ZBAO.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
ZBAO PE Valuation
ZBAO has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
ZBAO Forward outlook
There aren't enough analyst estimates for ZBAO to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over ZBAO in the latest year-over-year earnings comparison.
ZBAO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$14.56 | -541% |
| Q4 2024 | $5.25 | +$21.79 |
| Q2 2024 | $3.30 | +$15.20 |
| Q4 2023 | -$16.54 | -577% |
| Q2 2023 | -$11.90 | -241% |
ZBAO lost $14.56 per share over the past year, a bigger loss than the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
ZBAO has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus up 144% for ZBAO.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ZBAO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $30.9M | +41% |
| Q2 2025 | $19.6M | +31% |
| Q4 2024 | $22M | +74% |
| Q2 2024 | $14.9M | +89% |
| Q4 2023 | $12.6M | +85% |
| Q2 2023 | $7.9M | +2.9% |
| Q1 2023 | $3.8M | +1.7% |
| Q4 2022 | $6.8M | -22% |
ZBAO's revenue has grown year over year for seven quarters in a row: $31M last quarter, up 144% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 2.3% | +12 points |
| Q2 2025 | -44% | +58 points |
| Q4 2024 | 2.6% | +104 points |
| Q2 2024 | 19% | +12 points |
| Q4 2023 | -9.9% | -17 points |
| Q2 2023 | -101% | -114 points |
| Q1 2023 | -101% | -114 points |
| Q4 2022 | 7.1% | +1.5 points |
ZBAO's operating margin was 2.3% last quarter, up 12 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with ZBAO at down 603%.
ZBAO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2023 | -$32.3M | -$29M |
| Q1 2023 | -$15.5M | -$14M |
| Q4 2022 | $15.3M | +420% |
| Q3 2022 | $15.5M | +934% |
ZBAO's free cash flow was −$34M over the past year, against $14M the year before. Free cash flow isn't a meaningful measure for financial services companies like ZBAO.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ZBAO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ZBAO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +8K shares |
| 1 year | +18% | +99.1K shares |
ZBAO has 639,728 diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ZBAO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 1.0x | Very low |
| Q3 2022 | 5.5x | High |
| Q2 2022 | 1.1x | Healthy |
ZBAO's net debt is about a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like ZBAO.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ZBAO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.8 | Oversold |
| Stochastic | 0.1 | Oversold |
ZBAO's weekly RSI is 25 (oversold) and its Stochastic is 0 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ZBAO PE vs Financial Services Sector
| Metric | ZBAO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ZBAO has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has stronger trend alignment. BAC is above 1 of 5 weekly averages versus ZBAO above 0 of 4.
ZBAO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.75 | 88% below |
| 20 week MA | $7.43 | 97% below |
| 50 week MA | $27.9 | 99% below |
| 100 week MA | $43.1 | 100% below |
ZBAO is in a downtrend: it's below all four of its weekly moving averages, and 100% below its 100-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over ZBAO on returns for 2026, with the stronger performance.
ZBAO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $170.0 | $88.0 | -48% |
| 2025 | $88.0 | $44.7 | -49% |
| 2026 YTD | $44.7 | $0.21 | -100% |
ZBAO has finished every year since 2024 lower, and it's down 100% so far in 2026.